2238
A. Salgado et al. / Tetrahedron 59 (2003) 2231–2239
H-4); 2.67 (heptaplet, J¼6.3 Hz, 1H, CH(CH3)2); 1.50–
1.70 (m, 4H, CH2CH2CH3); 1.29 (d, J¼6.9 Hz, 3H, CH3);
1.08, 1.11 (each d, J¼6.3 Hz, 3H, CH(CH3)2); 0.92
(t, J¼7.6 Hz, 3H, CH2CH2CH3). 13C NMR (67.5 MHz,
CDCl3, d): 209.37 (C-3); 82.96 (C-2); 78.11 (C-4); 59.08
(CH(CH3)2); 34.66 (CH2CH2CH3); 21.89 and 22.07
(CH(CH3)2); 18.98 (CH2CH2CH3); 16.99 (CHCH3); 14.12
(CH2CH2CH3). IR (NaCl, cm21): 1803 (CvO). MS (EI,
m/z, %): 169 (Mþ, 4); 154 (10); 141 (37); 136 (5); 126 (43);
112 (45); 98 (100); 85 (16); 84 (37); 71 (20); 70 (64); 69
(11); 44 (36); 43 (41); 42 (34); 41 (44). Elemental analysis
C10H19NO; calculated 70.96% C, 11.31% H, 8.28% N;
found 70.78% C, 11.19% H, 8.22% N.
was evaporated in vacuo. The residue was chromatographed
(silica, column dimensions 13£2.5 cm, hexane–AcOEt 4:1).
Two compounds were isolated after pooling and evapo-
ration of the appropriate fractions.
First eluting compound. (2RS,3SR,4SR) 2-Benzyl-1-isopro-
pyl-4-methylazetidin-3-ol (15b, 87.5 mg, 0.40 mmol, 17%).
Rf: 0.31 (silica, AcOEt–hexane–MeOH 83:12:5). 1H NMR
(270 MHz, CDCl3, d): 7.15–7.31 (m, 5H, phenyl); 3.48 (t,
J2–3¼J3,4¼5.4 Hz, 1H, H-3); 3.07 (dd, Jgem¼12.8 Hz,
Jvic¼4.0 Hz, 1H, CH2Ph); 2.95 (m, 1H, H-2); 2.80 (m, 1H,
CH2Ph); 2.77 (m, 1H, H-4); 2.55 (heptet, J¼6.3 Hz, 1H,
CHMe2); 2.10 (s, 1H, OH); 1.28 (d, J¼6.3 Hz, 3H, CH3–
C-4); 1.01, 1.06 (each d, J¼6.3 Hz, 3H, CHMe2). 13C NMR
(67.5 MHz, CDCl3, d): 138.29 (Ph -ipso-); 128.89, 128.50
(Ph-2 and Ph-3); 126.27 (Ph-4); 74.37 (C-3); 72.28 (C-2);
66.76 (C-4); 58.87 (CHMe2); 42.73 (CH2Ph); 21.01 and
21.46 (CHMe2); 14.20 (Me–C-2). MS (EI, m/z, %):
C14H21NO requires 219.1623, found 219.1631 (Mþ, 3).
3.1.18. (2RS,4SR) 2-Benzyl-1-isopropyl-4-methylazeti-
din-3-one 13c. Yellow liquid (yield 51.1%, 3:1 mixture of
13c and 14c, considerable amount of pure 13c was obtained
after flash chromatography, silica, hexane–AcOEt 9:1). Rf:
1
0.20 (silica gel, hexane–AcOEt 9:1). H NMR (270 MHz,
CDCl3, d): 4.02 (dd, J¼7.6, 4.6 Hz, 1H, H-2); 3.80 (q,
J¼6.9 Hz, 1H, H-4); 3.04 (dd, Jgem¼14.3 Hz, Jvic¼7.6 Hz,
1H, CH2Ph); 2.90 (dd, Jgem¼14.3 Hz, Jvic¼4.6 Hz, 1H,
CH2Ph); 2.69 (heptaplet, J¼6.3 Hz, 1H, CH(CH3)2); 1.14
(d, J¼6.9 Hz, 3H, CH3); 1.06, 1.08 (each d, J¼6.3 Hz, 3H,
CH(CH3)2). 13C NMR (67.5 MHz, CDCl3, d): 207.96 (C-3);
137.72 (Ph -ipso-); 127.30, 128.40 and 129.50 (Ph); 83.52
(C-2); 77.95 (C-4); 58.56 (CH(CH3)2); 38.74 (CH2Ph);
21.74 and 22.16 (CH(CH3)2); 16.82 (CHCH3). IR (NaCl,
cm21): 1802 (CvO). MS (EI, m/z, %): no Mþ; 202 (3); 190
(4); 189 (22); 174 (4); 160 (1); 146 (14); 126 (100); 105 (6);
91 (12); 84 (39); 70 (10); 65 (4); 56 (19); 43 (16). Elemental
analysis C14H19NO; calculated 77.38% C, 8.81% H, 6.45%
N; found 77.32% C, 8.69% H, 6.58% N.
Second eluting compound. (2RS,3RS,4SR) 2-Benzyl-1-iso-
propyl-4-methyl azetidin-3-ol (15a, 159 mg, 0.73 mmol,
31%). Rf: 0.18 (silica gel, AcOEt–hexane–MeOH 83:12:5).
1H NMR (270 MHz, CDCl3, d): 7.00–7.20 (m, 5H, phenyl);
4.22 (m, 1H, H-3); 3.25 (m, 2H, H-2 and CH2Ph); 3.17 (m,
1H, H-4); 2.72–2.79 (m, 1H, CH2Ph); 2.51 (heptet, J¼
6.3 Hz, 1H, CHMe2); 1.91 (d, J¼7.9 Hz, 1H, OH); 1.20 (d,
J¼6.3 Hz, 3H, CH3–C-4); 1.01, 1.07 (each d, J¼6.3 Hz,
3H, CHMe2). 13C NMR (67.5 MHz, CDCl3, d): 139.32
(Ph-ipso-); 128.46 and 128.96 (Ph-2 and Ph-3); 126.07
(Ph-4); 68.52 (C-2); 66.36 (C-3); 62.12 (C-4); 58.45
(CHMe2); 36.39 (CH2Ph); 21.53 and 21.92 (CHMe2);
15.83 (Me–C-2). MS (EI, m/z, %): C14H21NO requires
219.1623, found 219.1637 (Mþ, 4).
3.1.19. (2RS,4SR) 2-Allyl-1-isopropyl-4-methylazetidin-
3-one 13d. Yellow residue (yield %, 4:1 mixture of 13d and
14d, analytical sample of 13d was obtained after preparative
1
GC). Rf: 0.42 (silica gel, hexane–AcOEt 5:1). H NMR
References
(270 MHz, CDCl3, d): 5.82–5.94 (m, 1H, CH2vCH);
5.06–5.14 (m, 2H, CH2vCH); 3.78–3.89 (m, 2H, H-2 and
H-4); 2.70 (heptet, J¼6.3 Hz, 1H, CH(CH3)2); 2.41–2.49
(m, 2H, CH2vCHCH2); 1.29 (d, J¼6.9 Hz, 3H, CH3); 1.09,
1.11 (each d, J¼6.3 Hz, 3H, CH(CH3)2). 13C NMR
(67.5 MHz, CDCl3, d): 208.15 (C-3); 133.87 (CH2vCH);
117.39 (CH2vCH); 83.52 (C-2); 78.24 (C-4); 58.78
(CH(CH3)2); 36.75 (CH2vCHCH2); 21.85 and 22.17
(CH(CH3)2); 16.89 (CHCH3). IR (NaCl, cm21): 1804
(CvO). MS (EI, m/z, %): C10H17NO requires 167.1310,
found 167.1316 (Mþ, 3).
1. De Kimpe, N. In Azetidines, Azetines and Azetes: Monocyclic.
Comprehensive Heterocyclic Chemistry II, Three and Four-
Membered Rings, with All Fused Systems Containing Four-
Membered Rings; Padwa, A., Katritzky, A. R., Rees, C. W.,
Scriven, E. F. V., Eds.; Elsevier: Oxford, 1996; Vol. 1B.
Chapter 1.18.
2. (a) De Kimpe, N.; Sulmon, P.; Schamp, N. J. Chem. Soc.,
Chem. Commun. 1985, 715–716. (b) De Kimpe, N.; Sulmon,
P.; Schamp, N. Tetrahedron 1988, 44, 3653–3670. (c) De
Kimpe, N.; Sulmon, P.; Schamp, N. J. Org. Chem. 1989, 54,
2587–2590. (d) De Kimpe, N.; Sulmon, P.; Schamp, N.
Tetrahedron 1989, 45, 2937–2955. (e) De Kimpe, N.;
Stevens, C. Synthesis 1993, 89–91. (f) De Kimpe, N.;
De Smaele, D. Tetrahedron Lett. 1994, 35, 8023–8026.
(g) Aelterman, W.; De Kimpe, N.; Declercq, J.-P. J. Org.
Chem. 1998, 63, 6–11. (h) De Smaele, D.; Dejaegher, Y.;
Duvey, G.; De Kimpe, N. Tetrahedron Lett. 2001, 42,
2373–2375.
3.1.20. Reduction of (2RS,4SR) 2-benzyl-1-isopropyl-4-
methylazetidin-3-one 13c. In a 50 ml round-bottomed
flask, provided with a magnetic stirrer and nitrogen inlet,
sodium borohydride (223 mg, 5.88 mmol) was added
dropwise to an ice-cooled solution of (2RS,4SR) 2-benzyl-
1-isopropyl-4-methyl azetidin-3-one (13c, 510 mg, 2.35 mmol)
in dichloromethane (2 ml) and absolute ethanol (18 ml).
This mixture was stirred while warmed up to ambient
temperature for 2 h, water (4 ml) was then added, and the
stirring was continued for another hour. Ethyl acetate
(10 ml) was added, and the aqueous phase was extracted
with ethyl acetate (2£5 ml). The combined organic phases
were dried over magnesium sulfate, filtered and the solvent
3. Salgado, A.; Boeykens, M.; Gauthier, C.; Declercq, J.-P.; De
Kimpe, N. Tetrahedron 2002, 58, 2763–2775.
¨
4. (a) Kobayashi, J.; Cheng, J.; Ishibashi, M.; Walchli, M. R.;
Yamamura, S.; Ohizumi, Y. J. Chem. Soc., Perkin Trans. 1
1991, 1135–1137. (b) Takikawa, H.; Maeda, T.; Seki, M.;
Koshino, H.; Mori, K. J. Chem. Soc., Perkin Trans. 1 1997,